Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04030871 · ClinicalTrials.gov registry record · NA

A Randomized, Pilot Study Comparing Cost Effectiveness on Two Commercially Available Gastric Feeding Tubes

A NA study, sponsored by Ohio State University.

Terminated
Registry status
NA
Development phase
7
Enrollment target

NCT04030871: Clinical Trial NA study, sponsored by Ohio State University.

NCT04030871 is a NA study that was terminated before completion, run by Ohio State University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04030871, a NA study, was terminated before completion, sponsored by Ohio State University.

TERMINATED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

This document is a protocol for a human research study. This study is to be conducted according to US and international standards of Good Clinical Practice (International Conference on Harmonization ICHE6, R2), the Code of Federal Regulations Title 21 parts 803 and 812, and other applicable government regulations and Institutional research policies and procedures. The purpose of the study is to compare the cost effectiveness and tolerability of standard of care gastrostomy tubes to newer capsule dome gastrostomy tubes. The newer tubes are significantly more expensive, therefore the aims of this study will be to determine economic feasibility of going to the new model. Data are lacking on the newer g-tubes in terms of longevity and cost-effectiveness

Primary Outcome

Time (metric is looking at Q3 month follow-up for one year)

Interventions

  • DEVICE Capsule Dome G-Tube
  • DEVICE Balloon Bolus feeding tube

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2019-10-25
Est. Completion 2023-12-30
Phase NA
Ohio State University

552 total trials

Why NCT04030871 stopped before completion

NCT04030871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Capsule Dome G-Tube is the first listed.

NCT04030871 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04030871 about?

NCT04030871 is a clinical study titled "A Randomized, Pilot Study Comparing Cost Effectiveness on Two Commercially Available Gastric Feeding Tubes". This document is a protocol for a human research study. This study is to be conducted according to US and international standards of Good Clinical Practice (International Conference on Harmonization ICHE6, R2), the Code of Federal Regulations Title 21 parts 803 and 812, and other applicable governme...

What is the current status of trial NCT04030871?

This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2019-10-25. Estimated completion is 2023-12-30.

What interventions are being tested in trial NCT04030871?

The interventions under investigation include: Capsule Dome G-Tube (DEVICE), Balloon Bolus feeding tube (DEVICE).

Who is sponsoring clinical trial NCT04030871?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04030871's enrollment target sits among peer trials

7 1982nd of 2000 higher than 18 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04030871, the US trial registry maintained by the National Library of Medicine. NCT04030871 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.